New theory may revolutionize treatment of endometriosis

 

Vancouver, Canada (May 11, 2021) — Endometriosis, a disease found in up to 10 per cent of women, has been enigmatic since it was first described. A new theory developed by researchers at Simon Fraser University suggests a previously overlooked hormone — testosterone — has a critical role in its development. The research could have direct impacts on diagnosis and treatment of the disease, signaling hope for women with endometriosis worldwide.

The disease is caused by endometrial tissue growing outside of the uterus, usually in the pelvic area, where it contributes to pain, inflammation, and infertility. But why some women get it, and others do not, has remained unclear.

The new research is based on recent findings that women with endometriosis developed, as fetuses in their mother’s womb, under conditions of relatively low testosterone, compared to women without endometriosis.

Werbung

According to the researchers’ theory, this low testosterone ‘programs’ the developing reproductive system of women to exhibit the unique suite of traits that is linked with endometriosis, including early menarche, short menstrual cycles, high pain sensitivity, high inflammation, and altered levels of the hormones that control ovulation and the menstrual cycle.

The researchers found their theory to be supported by a remarkable range of data in the literature, from genetics and development to endocrinology, morphology, life history, and evolutionary biology, thus providing the first comprehensive explanation for the traits associated with endometriosis.

The theory can explain almost all symptoms of endometriosis as downstream effects of low early-life testosterone. The findings are presented in two recent papers published in Evolution, Medicine and Public Health, and Evolutionary Applications.

“Low testosterone in early development is the strongest known correlate of endometriosis, and its effects can explain the majority of endometriosis symptoms,” says SFU biological sciences professor Bernard Crespi, a Canada Research Chair and co-author of the work with graduate student Natalie Dinsdale. “What’s more, the new theory has direct implications for endometriosis diagnosis and treatment.”

Crespi notes that testosterone has apparently been overlooked in studies of endometriosis because it is usually regarded as a ‘male’ hormone, even though it is known to have key effects in females as well.

“It is very common for researchers to focus on estrogen as a female hormone, and testosterone as a male hormone, but in reality, these are both critically important hormones in all humans,” says Ben Trumble, an assistant professor at the School of Human Evolution and Social Change at Arizona State University, who was not associated with these studies. “I applaud the authors for moving beyond this binary hormonal blind spot, and studying the full range of steroids that can impact women’s health.”

“This work establishes endometriosis as a developmental endocrine disorder, with roots in early life,” says Crespi. “It also clarifies the relationship of endometriosis with polycystic ovary syndrome, a disorder driven by too high, rather than too low, levels of prenatal testosterone. We show that polycystic ovary syndrome is essentially opposite to endometriosis in its causes, correlates, and major symptoms. As such, this work should help to transform our understanding of both disorders.”

 

 

 

AVAILABLE SFU EXPERTS

BERNARD CRESPI, professor, biological sciences | bernard_crespi@sfu.ca

 

CONTACT

MATT KIELTYKA, SFU Communications & Marketing
236.880.2187 | matt_kieltyka@sfu.ca

Simon Fraser University
Communications & Marketing | SFU Media Experts Directory
778.782.3210

 

ABOUT SIMON FRASER UNIVERSITY

As Canada’s engaged university, SFU works with communities, organizations and partners to create, share and embrace knowledge that improves life and generates real change. We deliver a world-class education with lifelong value that shapes change-makers, visionaries and problem-solvers. We connect research and innovation to entrepreneurship and industry to deliver sustainable, relevant solutions to today’s problems. With campuses in British Columbia’s three largest cities–Vancouver, Burnaby and Surrey–SFU has eight faculties that deliver 193 undergraduate degree programs and 127 graduate degree programs to more than 37,000 students. The university now boasts more than 165,000 alumni residing in 143 countries.

 

 


Simon Fraser University, 11.05.2021 (tB).

Schlagwörter: ,

MEDICAL NEWS

Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Having trouble falling asleep predicts cognitive impairment in later life
SARS-CoV-2 detectable — though likely not transmissible — on hospital…
Waking just one hour earlier cuts depression risk by double…
Moving one step closer to personalized anesthesia

SCHMERZ PAINCARE

Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern
Wenn Schmerzen nach einer OP chronisch werden

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…

ONKOLOGIE

Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung
Risikobasiertes Brustkrebs-Screening kosteneffektiv
Krebs – eine unterschätzte finanzielle Herausforderung

MULTIPLE SKLEROSE

Goldstandard für Versorgung bei Multipler Sklerose
Patienteninformationen zu Interferon-beta-Präparaten
Zulassung des S1P Modulators Ponesimod zur Behandlung von erwachsenen Patienten…
Neue S2k-Leitlinie für Diagnostik und Therapie der Multiplen Sklerose
Krankheitsbezogenes Kompetenznetz Multiple Sklerose: Stellungnahme zu SARS CoV 2 Impfdaten…

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung